Literature DB >> 16827154

Notch3 intracellular domain accumulates in HepG2 cell line.

Catia Giovannini1, Michela Lacchini, Laura Gramantieri, Pasquale Chieco, Luigi Bolondi.   

Abstract

BACKGROUND: By mediating local cell-cell interactions, the Notch signaling pathway seems to control a variety of processes from cell fate decisions during development, to stem cell renewal and to differentiation in many adult tissues. Hence, perturbed Notch signaling may be involved both in the development and the spread of cancer. The expression and the functional role of some major components of the Notch signaling pathway in human hepatocellular carcinoma (HCC) are poorly characterized.
MATERIALS AND METHODS: Notch3, HES1, Jagged1 and Delta1 were analyzed both at the RNA and protein levels in the HepG2 liver cell line derived from human HCC.
RESULTS: The results of this study demonstrated, for the first time, that both Jagged1 and Delta1 ligands and the downstream effector gene HES1 are expressed in the HepG2 actively proliferating cell line. Moreover, a high expression of Notch3 intracellular domain, indicative of constitutively activated Notch signaling, was the only detectable Notch3 subunit in HepG2.
CONCLUSION: These findings suggest that Notch3 may be involved in mechanisms controling the differentiation and the spread of HCC and that Notch3 activation may be dependent on both Jagged1 and Delta 1 ligands.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16827154

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  11 in total

Review 1.  Notch signaling proteins: legitimate targets for cancer therapy.

Authors:  Zhiwei Wang; Yiwei Li; Fazlul H Sarkar
Journal:  Curr Protein Pept Sci       Date:  2010-09       Impact factor: 3.272

Review 2.  Cancer stem cells and hepatocellular carcinoma.

Authors:  Zhixing Yao; Lopa Mishra
Journal:  Cancer Biol Ther       Date:  2009-09       Impact factor: 4.742

Review 3.  Novel therapeutic strategies for targeting liver cancer stem cells.

Authors:  Naoki Oishi; Xin Wei Wang
Journal:  Int J Biol Sci       Date:  2011-04-26       Impact factor: 6.580

4.  Hepatitis C virus NS3 protein can activate the Notch-signaling pathway through binding to a transcription factor, SRCAP.

Authors:  Atsushi Iwai; Tsutomu Takegami; Takuya Shiozaki; Tadaaki Miyazaki
Journal:  PLoS One       Date:  2011-06-06       Impact factor: 3.240

5.  Notch3 inhibition enhances sorafenib cytotoxic efficacy by promoting GSK3b phosphorylation and p21 down-regulation in hepatocellular carcinoma.

Authors:  Catia Giovannini; Michele Baglioni; Marco Baron Toaldo; Cristiano Ventrucci; Stefania D'Adamo; Mario Cipone; Pasquale Chieco; Laura Gramantieri; Luigi Bolondi
Journal:  Oncotarget       Date:  2013-10

6.  Suppression of p53 by Notch3 is mediated by Cyclin G1 and sustained by MDM2 and miR-221 axis in hepatocellular carcinoma.

Authors:  Catia Giovannini; Manuela Minguzzi; Michele Baglioni; Francesca Fornari; Ferdinando Giannone; Matteo Ravaioli; Matteo Cescon; Pasquale Chieco; Luigi Bolondi; Laura Gramantieri
Journal:  Oncotarget       Date:  2014-11-15

7.  Molecular and proteomic insight into Notch1 characterization in hepatocellular carcinoma.

Authors:  Catia Giovannini; Manuela Minguzzi; Filippo Genovese; Michele Baglioni; Alessandra Gualandi; Matteo Ravaioli; Maddalena Milazzo; Simona Tavolari; Luigi Bolondi; Laura Gramantieri
Journal:  Oncotarget       Date:  2016-06-28

8.  The significance of Notch1 compared with Notch3 in high metastasis and poor overall survival in hepatocellular carcinoma.

Authors:  Liang Zhou; Ning Zhang; Wenjie Song; Nan You; Qingjun Li; Wei Sun; Yong Zhang; Desheng Wang; Kefeng Dou
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

9.  Development of a Chemiluminescence Immunoassay for Serum YB-1 and its Clinical Application as a Potential Diagnostic Marker for Hepatocellular Carcinoma.

Authors:  Li Pu; Shi Jing; Guo Bianqin; Liu Ping; Liang Qindong; Liu Chenggui; Cheng Feng; Kuang Wenbin; Wang Qin; Dong Jinyu; Xia Qianfeng; Liu Yu; Tu Zhiguang
Journal:  Hepat Mon       Date:  2013-07-03       Impact factor: 0.660

10.  MicroRNA-206 overexpression promotes apoptosis, induces cell cycle arrest and inhibits the migration of human hepatocellular carcinoma HepG2 cells.

Authors:  Weiwei Liu; Chuanming Xu; Huifang Wan; Chunju Liu; Can Wen; Hongfei Lu; Fusheng Wan
Journal:  Int J Mol Med       Date:  2014-06-11       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.